← Back to guidelines
Cardiology27 papers

Juvenile hyaline fibromatosis

Last edited: 4/15/2026

Overview

Juvenile hyaline fibromatosis (JHF) is a rare autosomal recessive disorder characterized by abnormal proliferation of hyalinized fibrous tissue affecting the skin, mucosa, bones, joints, and internal organs, caused by mutations in the ANTXR2 gene 1.

Diagnosis

  • Clinical Features: Extreme pain at minimal handling, gingival hypertrophy, subcutaneous nodules, joint stiffness, contractures, and systemic involvement 1.
  • Histopathology: Presence of hyaline material in tissues 12.
  • Genetic Testing: Identification of mutations in ANTXR2 gene 1.
  • Grading System: Grade 4 indicates life-limiting disease with median survival of 15.0 months (9.5-24.0 months) 1.
  • Management

  • Supportive Care: Pain management, physical therapy for joint mobility 1.
  • Symptomatic Treatment: Addressing specific manifestations such as gingival hypertrophy and infections 1.
  • No Specific Dosing Mentioned: No specific drug classes or doses are detailed in the provided abstracts 1.
  • Special Populations

  • Pediatrics: Most prevalent in infants and children, with severe systemic involvement impacting early life 12.
  • Comorbidities: Recurrent infections, organ failure, and intractable diarrhea are significant comorbidities 1.
  • Key Recommendations

  • Genetic Testing for ANTXR2 Mutations: Essential for confirming diagnosis and understanding prognosis (Evidence: Strong 1).
  • Early Supportive Care: Focus on pain management and physical therapy to mitigate joint stiffness and contractures (Evidence: Moderate 1).
  • Monitor for Systemic Involvement: Regular assessment for signs of organ failure and recurrent infections to guide timely interventions (Evidence: Expert opinion 1).
  • References

    1 Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S et al.. Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations. Human mutation 2018. link 2 Gilaberte Y, González-Mediero I, López Barrantes V, Zambrano A. Juvenile hyaline fibromatosis with skull-encephalic anomalies: a case report and review of the literature. Dermatology (Basel, Switzerland) 1993. link 3 Siegle RL, Eyal FG, Rabinowitz JG. Air embolus following pulmonary interstitial emphysema in hyaline membrane disease. Clinical radiology 1976. link80020-7)

    Original source

    1. [1]
      Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations.Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S et al. Human mutation (2018)
    2. [2]
      Juvenile hyaline fibromatosis with skull-encephalic anomalies: a case report and review of the literature.Gilaberte Y, González-Mediero I, López Barrantes V, Zambrano A Dermatology (Basel, Switzerland) (1993)
    3. [3]
      Air embolus following pulmonary interstitial emphysema in hyaline membrane disease.Siegle RL, Eyal FG, Rabinowitz JG Clinical radiology (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG